Healthcare Global Enterprises Limited (HCG) - Total Assets

Latest as of March 2026: Rs39.23 Billion INR ≈ $424.21 Million USD

Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) holds total assets worth Rs39.23 Billion INR (≈ $424.21 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Healthcare Global Enterprises Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Healthcare Global Enterprises Limited - Total Assets Trend (2011–2026)

This chart illustrates how Healthcare Global Enterprises Limited's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Healthcare Global Enterprises Limited to see how much of total assets are deployed in long-term investments.

Healthcare Global Enterprises Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Healthcare Global Enterprises Limited's total assets of Rs39.23 Billion consist of 28.9% current assets and 71.1% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 13.7%
Accounts Receivable Rs4.24 Billion 10.8%
Inventory Rs598.20 Million 1.5%
Property, Plant & Equipment Rs0.00 0.0%
Intangible Assets Rs328.70 Million 0.8%
Goodwill Rs3.88 Billion 9.9%

Asset Composition Trend (2011–2026)

This chart illustrates how Healthcare Global Enterprises Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see HCG company net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Healthcare Global Enterprises Limited's current assets represent 28.9% of total assets in 2026, an increase from 13.0% in 2011.
  • Cash Position: Cash and equivalents constituted 13.7% of total assets in 2026, up from 1.5% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 2.0% in 2011.
  • Asset Diversification: The largest asset category is accounts receivable at 10.8% of total assets.

Healthcare Global Enterprises Limited Competitors by Total Assets

Key competitors of Healthcare Global Enterprises Limited based on total assets are shown below.

Company Country Total Assets
Aier Eye Hospital Group
SHE:300015
China CN¥36.58 Billion
PACS Group, Inc.
NYSE:PACS
USA $5.66 Billion
Xian International Medical Investment Co Ltd
SHE:000516
China CN¥9.50 Billion
Compass Pathways Plc
NASDAQ:CMPS
USA $210.35 Million
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
China CN¥8.17 Billion
RHÖN-KLINIKUM Aktiengesellschaft
XETRA:RHK
Germany €1.86 Billion
Metro Healthcare Indonesia
JK:CARE
Indonesia Rp4.19 Trillion
MLP Saglik Hizmetleri AS
IS:MPARK
Turkey TL89.94 Billion

Healthcare Global Enterprises Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.12 0.81 0.93
Quick Ratio 1.06 0.76 0.89
Cash Ratio 0.00 0.23 0.00
Working Capital Rs1.18 Billion Rs-2.03 Billion Rs-302.86 Million

Healthcare Global Enterprises Limited - Advanced Valuation Insights

This section examines the relationship between Healthcare Global Enterprises Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 7.04
Latest Market Cap to Assets Ratio 0.03
Asset Growth Rate (YoY) 10.7%
Total Assets Rs39.23 Billion
Market Capitalization $992.60 Million USD

Valuation Analysis

Below Book Valuation: The market values Healthcare Global Enterprises Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Healthcare Global Enterprises Limited's assets grew by 10.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Healthcare Global Enterprises Limited (2011–2026)

The table below shows the annual total assets of Healthcare Global Enterprises Limited from 2011 to 2026.

Year Total Assets Change
2026-03-31 Rs39.23 Billion
≈ $424.21 Million
+10.70%
2025-03-31 Rs35.43 Billion
≈ $383.19 Million
+30.87%
2024-03-31 Rs27.07 Billion
≈ $292.81 Million
+16.90%
2023-03-31 Rs23.16 Billion
≈ $250.47 Million
+4.35%
2022-03-31 Rs22.20 Billion
≈ $240.03 Million
+9.03%
2021-03-31 Rs20.36 Billion
≈ $220.14 Million
-9.66%
2020-03-31 Rs22.53 Billion
≈ $243.67 Million
+36.26%
2019-03-31 Rs16.54 Billion
≈ $178.82 Million
+14.54%
2018-03-31 Rs14.44 Billion
≈ $156.13 Million
+17.71%
2017-03-31 Rs12.26 Billion
≈ $132.63 Million
+17.52%
2016-03-31 Rs10.44 Billion
≈ $112.86 Million
+37.71%
2015-03-31 Rs7.58 Billion
≈ $81.96 Million
+10.04%
2014-03-31 Rs6.89 Billion
≈ $74.48 Million
-2.87%
2013-03-31 Rs7.09 Billion
≈ $76.67 Million
+28.50%
2012-03-31 Rs5.52 Billion
≈ $59.67 Million
+42.01%
2011-03-31 Rs3.89 Billion
≈ $42.02 Million
--

About Healthcare Global Enterprises Limited

NSE:HCG India Medical Care Facilities
Market Cap
$992.60 Million
Rs91.78 Billion INR
Market Cap Rank
#9094 Global
#439 in India
Share Price
Rs614.75
Change (1 day)
-1.89%
52-Week Range
Rs521.75 - Rs776.30
All Time High
Rs776.30
About

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more